Altro

targeting the mechanisms of treatment resistance in cancer with Nicholas Goldner | 222

0

0

0 Visualizzazioni· 09/26/23

cancer – Learning with Lowell
0 Iscritti

In

Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer... Source

Mostra di più

0 Commenti

Avanti il prossimo

Riproduzione automatica

Casa

Esplora di più

Aiuto